Endonovo Therapeutics, Inc. (OTCMKTS:ENDV) Short Interest Update

Endonovo Therapeutics, Inc. (OTCMKTS:ENDV) was the recipient of a significant increase in short interest in November. As of November 30th, there was short interest totalling 100,000 shares, an increase of 15.2% from the November 15th total of 86,800 shares. Based on an average daily volume of 14,295,400 shares, the short-interest ratio is presently 0.0 days.

Endonovo Therapeutics Price Performance

Shares of OTCMKTS:ENDV remained flat at $0.00 on Monday. The stock had a trading volume of 22,700,603 shares, compared to its average volume of 2,135,619. Endonovo Therapeutics has a twelve month low of $0.00 and a twelve month high of $0.01.

Endonovo Therapeutics Company Profile

Endonovo Therapeutics, Inc, a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema.